Rise and shine: Using a gene‐targeting approach aimed at identifying potential L‐threonine:uridine‐5′‐transaldolases that catalyze the formation of (5′S,6′S)‐C‐glycyluridine, a new bacterial translocase I inhibitor was discovered from an actinomycete following fermentation optimization.
During the course of screening for translocase I inhibitors, the new liposidomycin-related compounds, A-90289 A and B, were isolated from a culture broth of Streptomyces sp. SANK 60405. The structural elucidations were carried out by NMR and high-resolution mass spectral analyses, and they were classified as members of the liponucleoside antibiotics group with a sulfate group at the C-2¢ position. A-90289 A and B inhibited bacterial translocase I with IC 50 values of 36.5 ng ml À1 and 33.8 ng ml À1 , respectively.
Bacterial phospho-N-acetylmuramyl-pentapeptide translocase (translocase I: EC 2.7.8.13) is a key enzyme in peptidoglycan biosynthesis, and a known target of antibiotics. Here we report a new nucleoside inhibitor for translocase I, A-102395, isolated from the culture broth of the strain Amycolatopsis sp. SANK 60206. A-102395 is a new derivative of capuramycin that has the benzene with a uniquely substituted chain instead of an aminocaprolactam. A-102395 is a potent inhibitor of bacterial translocase I with IC 50 value of 11 nM, but possesses no antimicrobial activity against various strains tested.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.